Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder
Summary
- Naltrexone is an opiate-receptor antagonist used in the treatment of opioid dependence[Greenstein 1983; Roth 1997; Lobmaier 2008]
- Use among people with HIV and substance use disorder is discouraged as methadone and buprenorphine have higher retention rates[Stotts 2009]
- In 2010, the FDA approved extended-release naltrexone, administered as a monthly intramuscular injection, for the treatment of opioid dependence[Gastfriend 2011]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content